Abstract
Objectives: We aimed to improve previously described methods for confection of thoracoabdominal aortic aneurysms (TAAA) in porcine animal models, reducing surgical procedure time and specimen mortality. Methods: A total of 18 swine underwent a surgical procedure in order to confect a TAAA. All anesthetic precautions were taken. All the procedures were carried out via laparotomy and retroperitoneal access. An autologous peritoneum patch was used to make the aneurysm in 2 animals, and a bovine pericardium patch in 16. All the animals were followed up post-operatively, and were re-approached after 4 weeks for analysis of the aneurysm sac. The models that did not die in the post-operative period were euthanized under institutional recommendations Results: All the animals underwent laparotomy with retroperitoneal access. Two were submitted to an autologous peritoneum patch and 16 to a bovine pericardium patch. Three models underwent single suprarenal clamping; while 15 underwent sequential clamping. There were no differences in surgical time (p 0.207) or total clamping time (p 0.276) between groups. There was a higher mortality rate after 4 weeks in models submitted to single clamping (100%) compared to sequential clamping (26.7%) (p 0.0017). Conclusion: The experimental model of a thoracoabdominal bovine pericardium aneurysm which uses a sequential clamping technique, provides a stable and reliable platform with consistent anatomy and patency for up to four weeks. This model can be extremely valuable for assessing new endovascular therapy options in living organisms
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This experiment was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; 2016/0381-0).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
